Investigation of cellular senescence in the mouse liver caused by low dose fractionated X-ray therapy [0.03%]
低剂量分次照射引起的小鼠肝脏细胞衰老的初步研究
Xin Lan,Lina Cai,Lingyu Zhang et al.
Xin Lan et al.
Machine learning approach to estimation of in vivo measured dose and treatment planning for total body irradiation [0.03%]
基于机器学习的大分割全身照射治疗在体剂量估计和计划研究
Sangmin Lee,Jung-In Kim,Seonghee Kang et al.
Sangmin Lee et al.
Dosimetric advantages and clinical feasibility of a novel lateral decubitus position for left breast cancer patients undergoing PORT [0.03%]
一种新型侧卧位在左侧乳腺癌患者术后放疗中的剂量学优势及临床可行性研究
Yingying Zhou,Jinfeng Xu,Yuan Deng et al.
Yingying Zhou et al.
Practice of radiation therapy for squamous cell esophageal cancer in Austria - a survey on behalf of the ÖGRO-GIT [0.03%]
奥地利放射治疗鳞状细胞食管癌的实践——由ÖGRO-GIT发起的一项调查研究
Sabine Gerum,Patrick Clemens,Johanna Salinger et al.
Sabine Gerum et al.
Radionecrosis risk and local control after CyberKnife® fractionated stereotactic radiotherapy for brain metastases: an eight-year single-centre cohort [0.03%]
立体定向放射治疗后放射性脑坏死的风险和局部控制情况：8年单中心队列研究
Aurélia Alati,Philippe Giraud,Jean-Emmanuel Bibault et al.
Aurélia Alati et al.
Bridging radiotherapy before anti-CD19 CAR T-cell therapy for Large B-cell lymphoma - results from a single-center study [0.03%]
术前放疗联合抗CD19CAR-T细胞治疗大B细胞淋巴瘤的单中心研究结果
Sebastian M Stolz,Camilla von Wachter,Jonas Willmann et al.
Sebastian M Stolz et al.
Background: Radiotherapy (RT) with immunochemotherapy (ICT) followed by CAR T-cell therapy may have synergistic effects due to cytoreduction and enhancing antigen spread, thereby inducing anti-cancer immune responses. The...
Intensity-modulated radiotherapy/Volumetric modulated Arc therapy including four Brachytherapy fractions versus 3D conformal radiotherapy containing five Brachytherapy fractions in the treatment of cervical cancer [0.03%]
调强放疗/容积旋转调强放疗联合后装治疗与三维适形放疗及后装治疗用于宫颈癌的对比研究
Barin Feroz,Christoph Ebner,Sergej Skvortsov et al.
Barin Feroz et al.
Efficient clinical workflow for intraoperative electron radiation therapy with a mobile electron accelerator [0.03%]
移动电子直线加速器术中电子放射治疗的高效临床流程研究
Deepak K Shrestha,Amanda M Jackson,Steven M Herchko et al.
Deepak K Shrestha et al.
Clinical impact of novel cardiovascular and immune system dosimetric parameters in stage III NSCLC patients treated with radiotherapy [0.03%]
新型心血管和免疫系统放射剂量学参数在Ⅲ期非小细胞肺癌患者中的临床影响
Francesco Dionisi,Giulia Mascari,Isabella Sperduti et al.
Francesco Dionisi et al.
Predictors of survival for locally advanced rectal cancer patients with poor response to neoadjuvant chemoradiotherapy [0.03%]
新辅助放化疗反应不佳的局部晚期直肠癌患者的预后因素分析
Kasra Kolahdouzan,Romina Abyaneh,Erfan Barootchi et al.
Kasra Kolahdouzan et al.